Stock 2LYA HIGH TIDE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings High Tide Inc. Deutsche Boerse AG

Equities

2LYA

CA42981E4013

Market Closed - Deutsche Boerse AG
Other stock markets
 03:06:19 2024-06-07 am EDT 		5-day change 1st Jan Change
2.365 EUR +0.42% Intraday chart for High Tide Inc. +3.28% +65.38%
Jun. 04 High Tide Inc. to Open First Canna Cabana in Huntsville, Ontario CI
Jun. 04 High Tide Cheers Alberta's Decision to Allow Private Label Cannabis Sales MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 54% by 2026.
  • The company shows low valuation levels, with an enterprise value at 0.59 times its sales.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
HIGH TIDE INC. Stock High Tide Inc.
+65.38% 200M -
GREEN THUMB INDUSTRIES INC. Stock Green Thumb Industries Inc.
+12.91% 2.89B
D+
VERANO HOLDINGS CORP. Stock Verano Holdings Corp.
-12.41% 1.29B -
GLASS HOUSE BRANDS INC. Stock Glass House Brands Inc.
+53.49% 520M -
TERRASCEND CORP. Stock TerrAscend Corp.
-9.09% 424M -
CANTOURAGE GROUP SE Stock Cantourage Group SE
-5.99% 90.98M - -
MARIMED INC. Stock MariMed Inc.
-23.58% 79.73M -
GOLD FLORA CORPORATION Stock Gold Flora Corporation
+25.00% 57.52M -
C
NOVA CANNABIS INC. Stock Nova Cannabis Inc.
+24.72% 50.1M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. HITI Stock
  4. 2LYA Stock
  5. Ratings High Tide Inc.